Q&A: GSK vac­cine leader Judy Stew­art nav­i­gates vac­ci­na­tion slumps, al­ways-on mar­ket­ing and in­no­vat­ing da­ta tools

It’s been a tough cou­ple of years for tra­di­tion­al vac­cine mak­ers. While the Covid-19 pan­dem­ic spurred a flur­ry of in­no­va­tion and turned a white-hot spot­light …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER